Furthermore, MCC950 had no effect on IFN-γ secretion or killing ability of CTLs, which aligns fully with our finding that CD8+ T cells from CAPS patients, in contrast to their CD4+ T cells, have no intrinsically altered phenotype. This evidence concerns the gene CD8A and cryopyrin-associated periodic syndrome.